芒果视频

網站分類
登錄 |    
付平
0 票數:0 #醫生#
付平,四川大學華西醫院腎臟內科主任、教授。其2019年入選第七屆“榜樣中國-我心目中的名醫”----“內科十大名醫”榜單。付平從事臨床醫療、科研工作10余年,擅長糖尿病腎病、高血壓腎病和痛風腎病、腎小管間質纖維化的診斷和治療;在中藥與糖尿病腎病、中藥與腎臟纖維化、連續性血液凈化與危重疾病救治和循證腎臟病學等方面亦有較高的學術造詣;熟練掌握腹膜透析、血液透析技術。
  • 中文名: 付平
  • 性別:
  • 民族: 漢族
  • 畢業院校: 華西醫科大學
  • 職業職位: 主任醫(yi)師(shi)
詳(xiang)細(xi)介紹(shao) PROFILE +

人物簡介

付平,男(nan),四川(chuan)大學華(hua)西醫院腎臟內科教授(shou)、主任醫師、碩士生導師、腎臟內科主任。

主要經歷

1990年(nian)(nian)(nian)(nian)畢業于華西醫(yi)(yi)科大學(xue)(xue)(xue)(xue)(xue)臨床(chuang)醫(yi)(yi)學(xue)(xue)(xue)(xue)(xue)系,獲醫(yi)(yi)學(xue)(xue)(xue)(xue)(xue)學(xue)(xue)(xue)(xue)(xue)士學(xue)(xue)(xue)(xue)(xue)位(wei)。1993年(nian)(nian)(nian)(nian)獲醫(yi)(yi)學(xue)(xue)(xue)(xue)(xue)碩士學(xue)(xue)(xue)(xue)(xue)位(wei),畢業后留(liu)校工作。2002年(nian)(nian)(nian)(nian)攻讀在(zai)(zai)(zai)職博士,2005年(nian)(nian)(nian)(nian)7月獲醫(yi)(yi)學(xue)(xue)(xue)(xue)(xue)博士學(xue)(xue)(xue)(xue)(xue)位(wei)。1999年(nian)(nian)(nian)(nian)獲國際腎(shen)(shen)臟(zang)(zang)病(bing)(bing)學(xue)(xue)(xue)(xue)(xue)會青年(nian)(nian)(nian)(nian)學(xue)(xue)(xue)(xue)(xue)者(zhe)獎(jiang)學(xue)(xue)(xue)(xue)(xue)金(ISNFellowship),2000年(nian)(nian)(nian)(nian)赴(fu)澳大利亞(ya)Monash醫(yi)(yi)學(xue)(xue)(xue)(xue)(xue)中心(xin)進修一年(nian)(nian)(nian)(nian),獲國際腎(shen)(shen)臟(zang)(zang)病(bing)(bing)學(xue)(xue)(xue)(xue)(xue)者(zhe)稱號(ISNScholar)。2004年(nian)(nian)(nian)(nian)9月赴(fu)美(mei)國BaylorCollegeofMedicine,O’BrienKidneyCenter,RenalInflammationCenter進修學(xue)(xue)(xue)(xue)(xue)習3月。2003年(nian)(nian)(nian)(nian)被評為四川大學(xue)(xue)(xue)(xue)(xue)優秀(xiu)中青年(nian)(nian)(nian)(nian)骨干教師,2005年(nian)(nian)(nian)(nian)獲中華醫(yi)(yi)學(xue)(xue)(xue)(xue)(xue)會腎(shen)(shen)臟(zang)(zang)病(bing)(bing)學(xue)(xue)(xue)(xue)(xue)分會首屆留(liu)學(xue)(xue)(xue)(xue)(xue)歸國人員(yuan)論(lun)壇(tan)優秀(xiu)論(lun)文獎(jiang),并被批準為四川省學(xue)(xue)(xue)(xue)(xue)術(shu)(shu)技術(shu)(shu)帶頭人后備(bei)。從事臨床(chuang)醫(yi)(yi)療(liao)、教學(xue)(xue)(xue)(xue)(xue)和科研工作10余年(nian)(nian)(nian)(nian),在(zai)(zai)(zai)糖尿病(bing)(bing)腎(shen)(shen)病(bing)(bing)、高血壓腎(shen)(shen)病(bing)(bing)和痛風腎(shen)(shen)病(bing)(bing)、腎(shen)(shen)小管間質纖維化診(zhen)斷(duan)和治療(liao)方面有豐富的(de)臨床(chuang)經驗,在(zai)(zai)(zai)中藥與糖尿病(bing)(bing)腎(shen)(shen)病(bing)(bing)、中藥與腎(shen)(shen)臟(zang)(zang)纖維化、連續性血液凈(jing)化與危重疾病(bing)(bing)救治和循證腎(shen)(shen)臟(zang)(zang)病(bing)(bing)學(xue)(xue)(xue)(xue)(xue)等(deng)方面有較高的(de)學(xue)(xue)(xue)(xue)(xue)術(shu)(shu)造詣。熟(shu)練掌握(wo)腹膜透析(xi)(xi)、血液透析(xi)(xi)技術(shu)(shu)。

貢獻影響

擔(dan)任國(guo)(guo)際Cochrane中(zhong)心(CMB基金)、四川省(sheng)(sheng)科技(ji)廳攻關課題(ti)、國(guo)(guo)家及省(sheng)(sheng)中(zhong)醫藥管理局課題(ti)、四川大學(xue)青年基金等7項課題(ti)負責(ze)人,參(can)與國(guo)(guo)家、部(bu)省(sheng)(sheng)級課題(ti)9項。先(xian)后在國(guo)(guo)內外刊物上發表論文100余篇,參(can)與4部(bu)專著編寫,多次參(can)加(jia)國(guo)(guo)際會議(yi)并作口頭交流。獲四川省(sheng)(sheng)科技(ji)進步三等獎1項,成都市(shi)科技(ji)進步二等獎1項。科技(ji)進步二等獎1項(排(pai)名(ming)第(di)二)。

社會任職

國(guo)際腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)學(xue)會(hui)(hui)(hui)會(hui)(hui)(hui)員(yuan);中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)華(hua)(hua)醫學(xue)會(hui)(hui)(hui)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)學(xue)分(fen)(fen)(fen)會(hui)(hui)(hui)第七(qi)屆委(wei)(wei)(wei)(wei)員(yuan)會(hui)(hui)(hui)青年(nian)委(wei)(wei)(wei)(wei)員(yuan)會(hui)(hui)(hui)副主(zhu)(zhu)(zhu)任(ren)委(wei)(wei)(wei)(wei)員(yuan);中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)醫師協會(hui)(hui)(hui)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)學(xue)分(fen)(fen)(fen)會(hui)(hui)(hui)委(wei)(wei)(wei)(wei)員(yuan);中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)醫院(yuan)協會(hui)(hui)(hui)血液凈化(hua)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心管理分(fen)(fen)(fen)會(hui)(hui)(hui)常(chang)務委(wei)(wei)(wei)(wei)員(yuan);中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)華(hua)(hua)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)學(xue)會(hui)(hui)(hui)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)分(fen)(fen)(fen)會(hui)(hui)(hui)全國(guo)委(wei)(wei)(wei)(wei)員(yuan);中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)華(hua)(hua)醫學(xue)會(hui)(hui)(hui)老(lao)年(nian)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)學(xue)組全國(guo)委(wei)(wei)(wei)(wei)員(yuan);中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)華(hua)(hua)醫學(xue)會(hui)(hui)(hui)四(si)(si)川(chuan)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)學(xue)會(hui)(hui)(hui)委(wei)(wei)(wei)(wei)員(yuan)兼秘書;中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)華(hua)(hua)醫學(xue)會(hui)(hui)(hui)成都市腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)學(xue)會(hui)(hui)(hui)副主(zhu)(zhu)(zhu)任(ren)委(wei)(wei)(wei)(wei)員(yuan);四(si)(si)川(chuan)省(sheng)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)學(xue)會(hui)(hui)(hui)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)專委(wei)(wei)(wei)(wei)會(hui)(hui)(hui)副主(zhu)(zhu)(zhu)任(ren)委(wei)(wei)(wei)(wei)員(yuan);四(si)(si)川(chuan)省(sheng)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)西醫結合(he)學(xue)會(hui)(hui)(hui)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)專委(wei)(wei)(wei)(wei)會(hui)(hui)(hui)委(wei)(wei)(wei)(wei)員(yuan);《中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)華(hua)(hua)腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)雜志(zhi)》、《中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)實用內科雜志(zhi)》、《中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)臨床康復》、《西部醫學(xue)》、《中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)醫院(yuan)用藥(yao)評價(jia)與分(fen)(fen)(fen)析》、《中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)西醫結合(he)腎(shen)(shen)(shen)病(bing)(bing)(bing)(bing)雜志(zhi)》、《臨床腎(shen)(shen)(shen)臟(zang)病(bing)(bing)(bing)(bing)雜志(zhi)》等雜志(zhi)編委(wei)(wei)(wei)(wei)和常(chang)務編委(wei)(wei)(wei)(wei)。

詞條所在榜單
發表評論
您還未登錄,依《網絡安全法》相關要求,請您登錄賬戶后再提交發布信息。點擊登錄>>如您還未注冊,可,感謝您的理解及支持!
最新評(ping)論(lun)
暫無評論
網站提醒和聲明
本站(zhan)(zhan)為注冊(ce)用(yong)(yong)戶提(ti)供(gong)信息(xi)(xi)存儲空間服務,非“MAIGOO編(bian)輯上(shang)傳(chuan)提(ti)供(gong)”的文章(zhang)/文字均是注冊(ce)用(yong)(yong)戶自主發布(bu)上(shang)傳(chuan),不代(dai)表(biao)本站(zhan)(zhan)觀點(dian),版權(quan)歸原作者所有(you),如有(you)侵權(quan)、虛假(jia)信息(xi)(xi)、錯誤信息(xi)(xi)或任(ren)何問題,請(qing)及時(shi)聯系我們(men),我們(men)將在第一時(shi)間刪除或更正。 申請刪除>> 糾錯>> 投訴侵權>> 網(wang)頁(ye)上(shang)相(xiang)關信(xin)息(xi)的(de)知識產權歸網(wang)站方所有(包括但不(bu)限于文(wen)字、圖(tu)片、圖(tu)表、著作權、商(shang)標權、為用戶提供(gong)的(de)商(shang)業(ye)信(xin)息(xi)等),非經許可不(bu)得(de)抄襲或使用。
提(ti)交說明: 查看提交幫助>> 注冊登錄>>
頁面相關分類
熱門模塊
已有4083139個品牌入駐 更新521333個招商信息 已發布1611448個代理需求 已有1394907條品牌點贊